Stockscreener 앱 받기
22.69
2.95%
0.65
시장 영업 전:
22.06
-0.63
-2.78%
Pacira Biosciences Inc 주식(PCRX)의 최신 뉴스
PCRX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. ... - Bluefield Daily Telegraph
PCRX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 14 Deadline in Securities Class Action – PCRX - GlobeNewswire Inc.
PCRX LAWSUIT ALERT: Levi & Korsinsky Notifies Pacira BioSciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
The Gross Law Firm Reminds Pacira BioSciences, Inc. Investors of - GuruFocus.com
Pacira BioSciences, Inc. Investors: Please contact the - GlobeNewswire
Pacira BioSciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & ... - Bluefield Daily Telegraph
Pacira BioSciences, Inc. Securities Fraud Class Action - GlobeNewswire
FINAL REMINDER PCRX DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Pacira BioSciences, Inc. Investors to Participate in the Class Action Lawsuit - Markets Insider
Analysts Set Pacira BioSciences, Inc. (NASDAQ:PCRX) PT at $27.22 - Defense World
Pacira BioSciences, Inc. Class Action: The Gross Law Firm Reminds Pacira Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025PCRX - PR Newswire
Class Action Filed Against Pacira BioSciences, Inc. (PCRX)March 14, 2025 Deadline to JoinContact Levi & Korsinsky - PR Newswire
Faruqi & Faruqi Reminds Pacira BioSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025PCRX - StreetInsider.com
Levi & Korsinsky Notifies Shareholders of Pacira BioSciences, In - GuruFocus.com
FINAL PCRX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Pacira BioSciences, Inc. Investors to Join the Class Action Lawsuit - Markets Insider
(PCRX) On The My Stocks Page - Stock Traders Daily
PACIRA BIOSCIENCES 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Pacira BioSciences, Inc.PCRX - Business Wire
Investors in Pacira BioSciences, Inc. Should Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your RightsPCRX - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Pacira Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesPCRX - PR Newswire
PCRX Shareholders Have Opportunity to Lead Pacira BioSciences, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - Markets Insider
Pacira BioSciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your RightsPCRX - ACCESS Newswire
Levi & Korsinsky Reminds Pacira BioSciences, Inc. Investors - GlobeNewswire
Shareholders that lost money on Pacira BioSciences, Inc.(PCRX) should contact The Gross Law Firm about pending Class ActionPCRX - PR Newswire
PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Pacira BioSciences, Inc.(PCRX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
PCRX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira - GlobeNewswire
Shareholders that lost money on Pacira BioSciences, Inc. PCRX) should contact Levi & ... - Bluefield Daily Telegraph
Shareholders that lost money on Pacira BioSciences, Inc. - GlobeNewswire
Faruqi & Faruqi Reminds Pacira BioSciences Investors of the - GlobeNewswire
PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Pacira BioSciences, Inc. (NASDAQ: PCRX) Investor Alert: Deadline in Lawsuit on March 14, 2025 - openPR
PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
PCRX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Pacira - GlobeNewswire
PCRX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to - Bluefield Daily Telegraph
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
PCRX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
The Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc.(PCRX) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
Class Action Filed Against Pacira BioSciences, Inc. (PCRX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Pacira BioSciences and Golden Entertainment in the Box have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Bull of the Day: Pacira BioSciences (PCRX) - Yahoo Finance
Pacira BioSciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your RightsPCRX - ACCESS Newswire
PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA - GlobeNewswire
PCRX Deadline: PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit - PR Newswire
PCRX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira BioSciences, Inc. LawsuitPCRX - PR Newswire
PCRX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to - The Bakersfield Californian
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira - GlobeNewswire
Investors in Pacira BioSciences, Inc. Should Contact The - GlobeNewswire
NASDAQ: PCRX Lawsuit Alert: Investors Who Purchased Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) Should Contact the Shareholders Foundation - Newswire
PCRX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Perkins Coie Advises Pacira BioSciences, Inc. in Its Acquisition of GQ Bio Therapeutics - Perkins Coie
PCRX Lawsuit Alert! Class Action Lawsuit Against Pacira Biosciences, Inc. - TipRanks
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira LawsuitPCRX - PR Newswire
Pacira BioSciences (NASDAQ:PCRX) Price Target Raised to $70.00 - Defense World
Pacira BioSciences (PCRX) Surges as Barclays Raises Price Target: What Investors Need to Know - Apna Kal
Is Pacira BioSciences, Inc. (PCRX) the Best Small Cap Pharma Stocks to Buy Now? - Insider Monkey
0.77%
0.63%
자본화:
|
볼륨(24시간):